Evaluation of Suspected Monoclonal Gammopathies: Experience in a Tertiary Care Hospital

Merlini, 1988, The laboratory investigation of monoclonal components, Haematologica, 73, 79 Kyle, 1981, The clinical aspects of biclonal gammopathies — Review of 57 cases, Am J Med, 71, 999, 10.1016/0002-9343(81)90326-0 Keren, 1999, Guidelines for clinical and laboratory evaluation of patients with monoclonal gammopathies, Arch Path Lab Med, 123, 106, 10.5858/1999-123-0106-GFCALE Kyle, 2003, Review of 1027 patients with newly diagnosed multiple myeloma, Mayo Clin Proc, 78, 21, 10.4065/78.1.21 Kyle, 2002, Diagnosis of multiple myeloma, Semin Oncol, 29, 2, 10.1053/sonc.2002.34069 Kyle, 1991, Immunoglobulins and laboratrory recognition of monoclonal proteins, 373 Greipp, 1989, Monoclonal gammopathies: new approaches to clinical problems in diagnosis and prognosis, Blood Rev, 3, 222, 10.1016/0268-960X(89)90030-1 Keren, 1988, Strategy to diagnose monoclonal gammopathies in serum: high resolution electrophoresis, immunofixation, and kappa/lambda quantification, Clin Chem, 34, 2196, 10.1093/clinchem/34.11.2196 Kyle, 1992, Diagnostic criteria of multiple myeloma, Hematol Oncol Clin North Am, 6, 347, 10.1016/S0889-8588(18)30348-4 San Miguel, 1995, A new staging system for multiple myeloma based on the number of S-Phase plasma cells, Blood, 85, 448, 10.1182/blood.V85.2.448.448 San Miguel, 1995, A new staging system for multiple myeloma based on the number of S-phase plasma cells, Blood, 85, 448, 10.1182/blood.V85.2.448.448 Mehta, 2002, Laboratory investigations in myeloma, 243 Garewal, 1984, Serum beta 2 - microglobulin in the initial staging and subsequent monitoring of monoclonal plasma cell disorders, J Clin Oncol, 2, 51, 10.1200/JCO.1984.2.1.51 Boccadoro, 1989, Multiple myeloma: beta-2 microglobulin is not a useful follow-parameter, Acta Haematol, 82, 122, 10.1159/000205322 Cuzick, 1990, Long-term prognostic value of serum beta 2 microglobulin in myelomatosis, Br J Haematol, 75, 506, 10.1111/j.1365-2141.1990.tb07790.x Pelliniemi, 1995, Immunoreactive interleukin - 6 and acute phase proteins as prognostic factors in multiple myeloma, Finnish Leukemia Group Blood, 85, 765